Business Development

Thrombotargerts' approach for out-license is to perform the clinical proof of concept prior to the out-license of its products under development.

Thrombotargets is interested in early stage projects in hemostasis and wound healing, or in late stage/commercial products for the commercialization in its territory through Thrombotargets Development.
We have some on-going joint development projects, and are open to new projects in our fields of interest (Thrombosis, Fibrinolysis, Hemostasis and Wound Healing).